Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001971967 | SCV002203090 | pathogenic | not provided | 2022-03-14 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln16Glufs*24) in the LPL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LPL are known to be pathogenic (PMID: 11334614). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with LPL-related conditions (PMID: 17717288, 33303402). This variant is also known as p.Q-12E>11X. For these reasons, this variant has been classified as Pathogenic. |